An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis.
H Y WangL QiuC Y OuZ Q LinZ D HuangP ChenQ MaY R LuH RanWeibin LiuPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)
Our results suggest that inactivated virus vaccines against COVID-19 may be safe for patients with MG whose condition is stable. Patients with generalized MG may be more likely to develop increased muscle weakness after vaccination.